Kazia Therapeutics (KZIA) Non-Current Deferred Tax Liability (2011 - 2025)

Kazia Therapeutics' Non-Current Deferred Tax Liability history runs 11 years deep, the most recent figure standing at $178345.0 for Q4 2025.

• Quarterly Non-Current Deferred Tax Liability fell 85.51% year-over-year to $178345.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $178345.0 (down 85.51% YoY) and the FY2025 annual result came in at $173960.2, down 86.92% from the prior year.
• Non-Current Deferred Tax Liability was $178345.0 for Q4 2025 at Kazia Therapeutics, up from $173960.2 in the prior quarter.
• Across five years, Non-Current Deferred Tax Liability topped out at $2.3 million in Q2 2021 and bottomed at $173960.2 in Q2 2025.
• A 5-year average of $1.4 million and a median of $1.4 million in 2023 frame the typical range for Non-Current Deferred Tax Liability.
• Annual changes were most pronounced in 2021 — Non-Current Deferred Tax Liability rose 0.79% — and 2025, when it plunged 86.92%.
• Kazia Therapeutics' Non-Current Deferred Tax Liability stood at $2.1 million in 2021, then retreated by 21.15% to $1.7 million in 2022, then decreased by 21.9% to $1.3 million in 2023, then dropped by 6.29% to $1.2 million in 2024, then tumbled by 85.51% to $178345.0 in 2025.
• Business Quant data shows KZIA's Non-Current Deferred Tax Liability at $178345.0 in Q4 2025, $173960.2 in Q2 2025, and $1.2 million in Q4 2024.